MRNA News and Press, Moderna Inc. From 02/13/26

2026-02-13 12:48:45 ET More on Moderna Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case Moderna reaffirms 2026 growth outlook desp...

2026-02-13 12:47:49 ET Moderna, Inc. (MRNA) Q4 2025 Earnings Call February 13, 2026 8:00 AM EST Company Participants Lavina Talukdar - Senior VP & Head of Investor Relations Stéphane Bancel - CEO & Director James Mock - Chief Financial Officer St...

2026-02-13 09:39:16 ET Image source: The Motley Fool. Feb. 13, 2026 at 8:00 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-13 08:44:12 ET More Related Stories Arista Networks Raises The Bar - Hyperscalers Unleash Capex (Q4 Review) Twilio Inc. (TWLO) Q4 2025 Earnings Call Transcript Twilio Inc. 2025 Q4 - Results - Earnings Call Presentation Twilio's outlook draws mixed rea...

2026-02-13 07:35:07 ET More on Moderna Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case Moderna: Analyzing The January Rally And The Road Ahead (Rating Upgrade) Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? ...

2026-02-13 07:08:03 ET More on Moderna Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case Moderna: Analyzing The January Rally And The Road Ahead (Rating Upgrade) Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? ...

2026-02-13 07:01:52 ET More on Moderna Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case Moderna: Analyzing The January Rally And The Road Ahead (Rating Upgrade) Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? ...

Reports fourth quarter revenue of $0.7 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.11) Reports full-year revenue of $1.9 billion, GAAP net loss of $(2.8) billion and GAAP diluted EPS of $(7.26) Reiterates plan to deliver up to 10% revenue growth and GAAP operating expen...

Air Canada Inc. (ACDVF) is expected to report $0.2 for Q4 2025 Edesa Biotech Inc. (EDSA) is expected to report $-0.28 for Q1 2026 Advance Auto Parts Inc. (AAP) is expected to report $0.41 for Q4 2025 Neuphoria Therapeutics Inc. (NEUP) is expected to report $-0.56 for Q2 2026 Kirin...

2026-02-12 11:30:00 ET A few years ago, investors rushed to buy Moderna (NASDAQ: MRNA) stock. The biotech company had brought its coronavirus vaccine to market in less than a year and quickly saw earnings take off. The stock soared more than 700% through 2020 and into the first week...